The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
Are All Routine Spondyloarthritis Outpatient Visits Considered Useful by Rheumatologists? An Exploratory Clinical Practice Study |
J Rheumatol. 2022 Nov;49(11):1214-1220. doi: 10.3899/jrheum.220037. Epub 2022 Jun 1.
|
| 2 | |
The association between ankylosing spondylitis and psychiatric disorders: Insights from a population based cross-sectional database |
J Affect Disord. 2023 Feb 15;323:788-792. doi: 10.1016/j.jad.2022.12.024. Epub 2022 Dec 12.
Mahmud Omar 1, Niv Ben-Shabat 2, Avishai M Tsur 3, Arnon D Cohen 4, Abdulla Watad 5, Howard Amital 2, Kassem Sharif 6 |
| 3 | |
Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis |
Front Med (Lausanne). 2022 Dec 21;9:1078325. doi: 10.3389/fmed.2022.1078325.eCollection 2022. Cristina Fernández-Carballido 1, Vega Jovaní 2, Emma Beltrán Catalán 3, Manuel José Moreno-Ramos 4, Jesús Sanz Sanz 5, Adela Gallego 6, M Luz García Vivar 7, José Manuel Rodríguez-Heredia 8, Cristina Sanabra 9, Carlos Sastré 9 |
| 5 | |
Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis |
Rheumatol Int. 2022 Nov 28. doi: 10.1007/s00296-022-05248-4. Online ahead of print.
Stefan Kleinert 1 2, Florian Schuch 3, Praxedis Rapp 3, Monika Ronneberger 3, Joerg Wendler 3, Patrizia Sternad 4, Florian Popp 4, Peter Bartz-Bazzanella 5, Cay von der Decken 6, Kirsten Karberg 7, Georg Gauler 8, Patrick Wurth 8, Susanna Späthling-Mestekemper 9, Christoph Kuhn 10, Matthias Englbrecht 11, Wolfgang Vorbrüggen 12, Georg Adler 13, Martin Welcker 4 |
| 6 | |
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study |
Arthritis Rheumatol. 2022 Dec;74(12):1943-1958.doi: 10.1002/art.42282. Epub 2022 Nov 7.
Xenofon Baraliakos 1, Atul Deodhar 2, Maxime Dougados 3, Lianne S Gensler 4, Anna Molto 3, Sofia Ramiro 5, Alan J Kivitz 6, Denis Poddubnyy 7, Marga Oortgiesen 8, Thomas Vaux 9, Carmen Fleurinck 10, Julie Shepherd-Smith 9, Christine de la Loge 10, Natasha de Peyrecave 10, Désirée van der Heijde 11 |
| 7 | |
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis |
Rheumatology (Oxford). 2022 Nov 28;61(12):4741-4751. doi: 10.1093/rheumatology/keac174.
Michael Nissen 1, Bénédicte Delcoigne 2, Daniela Di Giuseppe 2, Lennart Jacobsson 3, Merete Lund Hetland 4 5, Adrian Ciurea 6, Lucie Nekvindova 7 8, Florenzo Iannone 9, Nurullah Akkoc 10, Tuulikki Sokka-Isler 11, Karen Minde Fagerli 12, Maria Jose Santos 13 14, Catalin Codreanu 15, Manuel Pombo-Suarez 16, Ziga Rotar 17 18, Bjorn Gudbjornsson 19 20, Irene van der Horst-Bruinsma 21, Anne Gitte Loft 22 23, Burkhard Möller 24, Herman Mann 25, Fabrizio Conti 26, Gozde Yildirim Cetin 27, Heikki Relas 28, Brigitte Michelsen 29 30, Pedro Avila Ribeiro 31, Ruxandra Ionescu 32, Carlos Sanchez-Piedra 33, Matija Tomsic 17 18, Árni Jón Geirsson 34, Johan Askling 35 36, Bente Glintborg 37 38, Ulf Lindström 39 |
| 8 | |
Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis |
Rheumatol Int. 2022 Nov 28. doi: 10.1007/s00296-022-05248-4. Online ahead of print.
Stefan Kleinert 1 2, Florian Schuch 3, Praxedis Rapp 3, Monika Ronneberger 3, Joerg Wendler 3, Patrizia Sternad 4, Florian Popp 4, Peter Bartz-Bazzanella 5, Cay von der Decken 6, Kirsten Karberg 7, Georg Gauler 8, Patrick Wurth 8, Susanna Späthling-Mestekemper 9, Christoph Kuhn 10, Matthias Englbrecht 11, Wolfgang Vorbrüggen 12, Georg Adler 13, Martin Welcker 4 |
| 9 | |
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study |
Arthritis Rheumatol. 2022 Dec;74(12):1943-1958.doi: 10.1002/art.42282. Epub 2022 Nov 7.
Xenofon Baraliakos 1, Atul Deodhar 2, Maxime Dougados 3, Lianne S Gensler 4, Anna Molto 3, Sofia Ramiro 5, Alan J Kivitz 6, Denis Poddubnyy 7, Marga Oortgiesen 8, Thomas Vaux 9, Carmen Fleurinck 10, Julie Shepherd-Smith 9, Christine de la Loge 10, Natasha de Peyrecave 10, Désirée van der Heijde 11 |
| 10 | |
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial |
Ann Rheum Dis. 2022 Nov;81(11):1515-1523. doi: 10.1136/ard-2022-222608.Epub 2022 Jul 4.
Désirée van der Heijde 1, Xenofon Baraliakos 2, Joachim Sieper 3, Atul Deodhar 4, Robert D Inman 5, Hideto Kameda 6, Xiaofeng Zeng 7, Yunxia Sui 8, Xianwei Bu 8, Aileen L Pangan 8, Peter Wung 8, In-Ho Song 8 |
| 11 | |
Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study |
Scand J Rheumatol. 2022 Nov;51(6):506-512.doi: 10.1080/03009742.2021.1967046. Epub 2021 Nov 2.
T Rusman 1, M T Nurmohamed 1 2, S Hoekstra 1, C J van Denderen 2, R F van Vollenhoven 1, M Boers 1 3, M M Ter Wee 1 3, I E van der Horst-Bruinsma 1 |
| 12 | |
Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors |
J Rheumatol. 2022 Nov 1;jrheum.220061. doi: 10.3899/jrheum.220061. Online ahead of print.
Maria Konsta 1, Michael T Nurmohamed 1, Alexios Iliopoulos 1, Petros P Sfikakis 1, J Christiaan van Denderen 1, Ingrid Visman 1, Grigorios T Sakelariou 1, Irene E van der Horst-Bruinsma 1 |
| 13 | |
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry |
Rheumatol Ther. 2022 Nov 4. doi: 10.1007/s40744-022-00504-2. Online ahead of print.
Martin J Bergman 1, Patrick Zueger 2, Jayeshkumar Patel 2, Christopher D Saffore 3, Ia Topuria 4, Cristi Cavanaugh 4, Siran Fang 2, Jerry Clewell 2, Alexis Ogdie 5 |
| 14 | |
Management of Axial Spondyloarthritis - Insights into Upadacitinib |
Drug Des Devel Ther. 2022 Oct 19;16:3609-3620. doi: 10.2147/DDDT.S330413.eCollection 2022.
|
| 15 | |
Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders |
Adv Ther. 2022 Dec;39(12):5327-5350. doi: 10.1007/s12325-022-02321-z.Epub 2022 Oct 7.
Akira Yuasa 1, Naohiro Yonemoto 1, Kazumasa Kamei 1, Toshiaki Murofushi 2, Michael LoPresti 2, Ankush Taneja 3, Jake Horgan 4, Shunya Ikeda 5 |
| 16 | |
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms |
Curr Rheumatol Rep. 2022 Oct;24(10):310-320. doi: 10.1007/s11926-022-01084-4.Epub 2022 Jul 21.
|
| 17 | |
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis |
Ann Rheum Dis. 2022 Oct 21;ard-2022-223298. doi: 10.1136/ard-2022-223298.Online ahead of print.
Casper Webers 1 2, Augusta Ortolan 3 4, Alexandre Sepriano 4 5, Louise Falzon 6, Xenofon Baraliakos 7, Robert B M Landewé 8 9, Sofia Ramiro 4 9, Désirée van der Heijde 4, Elena Nikiphorou 4 10 11 |
| 18 | |
Surgery for degenerative cervical myelopathy in patients with rheumatoid arthritis and ankylosing spondylitis: a nationwide registry-based study with patient-reported outcomes |
Acta Neurochir (Wien). 2022 Oct 15. doi: 10.1007/s00701-022-05382-9. Online ahead of print.
Siril T Holmberg 1 2, Agnete M Gulati 3, Tonje Okkenhaug Johansen 4 5, Øyvind O Salvesen 6, Vetle Vangen Lønne 4 5, Tore K Solberg 7 8, Erling A Tronvik 5 9, Øystein P Nygaard 4 5 10, Sasha Gulati 4 5 10 |
| 19 | |
Further Simplified Clinimetry Using a Multidimensional Health Assessment Questionnaire |
J Rheumatol. 2022 Oct 1;jrheum.220769. doi: 10.3899/jrheum.220769. Online ahead of print.
|
| 20 | |
Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB) |
Vaccine. 2022 Oct 12;40(43):6206-6210. doi: 10.1016/j.vaccine.2022.09.056. Epub 2022 Sep 26.
Sandro T Stoffel 1, Angelo Colaninno 2, René Bräm 2, Matthias Schwenkglenks 3 |
| 21 | |
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update |
Ann Rheum Dis. 2022 Oct 21;ard-2022-223296. doi: 10.1136/ard-2022-223296.Online ahead of print.
Sofia Ramiro 1 2, Elena Nikiphorou 3 4, Alexandre Sepriano 3 5, Augusta Ortolan 6, Casper Webers 7, Xenofon Baraliakos 8, Robert B M Landewé 9 10, Filip E Van den Bosch 11 12, Boryana Boteva 13, Ann Bremander 14 15, Philippe Carron 11 12, Adrian Ciurea 16, Floris A van Gaalen 3, Pál Géher 17, Lianne Gensler 18, Josef Hermann 19, Manouk de Hooge 11, Marketa Husakova 20, Uta Kiltz 8, Clementina López-Medina 21 22, Pedro M Machado 23 24 25, Helena Marzo-Ortega 26, Anna Molto 27, Victoria Navarro-Compán 28, Michael J Nissen 29, Fernando M Pimentel-Santos 5, Denis Poddubnyy 30, Fabian Proft 30, Martin Rudwaleit 31, Mark Telkman 32, Sizheng Steven Zhao 33, Nelly Ziade 34 35, Désirée van der Heijde 3 |
| 22 | |
Why do some patients have severe sacroiliac disease but no syndesmophytes in Ankylosing Spondylitis? Data from a Nested Case-Control Study |
J Rheumatol. 2022 Oct 1;jrheum.211230. doi: 10.3899/jrheum.211230. Online ahead of print.
Lauren K Ridley 1, Mark C Hwang 1, John D Reveille 1, Lianne S Gensler 1, Mariko L Ishimori 1, Matthew A Brown 1, Mohammad H Rahbar 1, Amirali Tahanan 1, Michael M Ward 1, Michael H Weisman 1, Thomas J Learch 1 |
| 23 | |
Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5,900 Patients From Israel |
Arthritis Care Res (Hoboken). 2022 Oct;74(10):1614-1622. doi: 10.1002/acr.24616.Epub 2022 Jun 28.
Niv Ben-Shabat # 1, Aviv Shabat # 2, Abdulla Watad 3, Khalaf Kridin 4, Nicola Luigi Bragazzi 5, Dennis McGonagle 6, Doron Comaneshter 7, Arnon D Cohen 8, Howard Amital 9 |
| 24 | |
Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis |
J Manag Care Spec Pharm. 2022 Sep;28(9):1008-1020. doi: 10.18553/jmcp.2022.28.9.1008.
Alexis Ogdie 1, Mark Hwang 2, Phani Veeranki 3 4, Alexandria Portelli 3, Steven Sison 3, Jason Shafrin 3 5, Sofia Pedro 6, Nina Kim 7, Esther Yi 8, Kaleb Michaud 6 9 |
| 25 | |
Driving Difficulties in Patients With Axial Spondyloarthritis: Results From the Scotland Registry for Ankylosing Spondylitis |
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1541-1549. doi: 10.1002/acr.24595.Epub 2022 Jun 29.
LaKrista Morton 1, Gary J Macfarlane 1, Gareth Jones 1, Karen Walker-Bone 2, Rosemary Hollick 1 |
| 26 | |
Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort |
Rheumatology (Oxford). 2022 Aug 11;keac432. doi: 10.1093/rheumatology/keac432.Online ahead of print.
Mikhail Protopopov 1, Fabian Proft 1, Stephanie Wichuk 2, Pedro M Machado 3, Robert G Lambert 4, Ulrich Weber 5, Susanne Juhl Pedersen 6 7, Mikkel Østergaard 6 7, Joachim Sieper 1, Martin Rudwaleit 8, Xenofon Baraliakos 9, Walter P Maksymowych 2, Denis Poddubnyy 1 10 |
| 27 | |
Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care |
Semin Arthritis Rheum. 2022 Aug;55:152006. doi: 10.1016/j.semarthrit.2022.152006.Epub 2022 Apr 15.
Uta Kiltz 1, Thomas Wiatr 2, Imke Redeker 2, Xenofon Baraliakos 2, Kirill Fedorov 2, J Braun 2 |
| 28 | |
The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease |
Rheumatol Int. 2022 Aug 8. doi: 10.1007/s00296-022-05174-5.Online ahead of print.
Marcus Kenyon 1, Sinead Maguire 2, Anna Rueda Pujol 3, Finbar O'Shea 2, Ross McManus 3 |
| 29 | |
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial |
Lancet. 2022 Jul 30;400(10349):369-379.doi: 10.1016/S0140-6736(22)01212-0.
Atul Deodhar 1, Filip Van den Bosch 2, Denis Poddubnyy 3, Walter P Maksymowych 4, Désirée van der Heijde 5, Tae-Hwan Kim 6, Mitsumasa Kishimoto 7, Ricardo Blanco 8, Yuanyuan Duan 9, Yihan Li 9, Aileen L Pangan 9, Peter Wung 9, In-Ho Song 9 |
| 30 | |
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-a Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease |
J Pers Med. 2022 Jul 19;12(7):1174. doi: 10.3390/jpm12071174.
Maurizio Benucci 1, Arianna Damiani 1, Edda Russo 2, Francesca Li Gobbi 1, Valentina Grossi 3, Amedeo Amedei 2, Maria Infantino 3, Mariangela Manfredi 3 |
| 31 | |
Sleep and spa therapies: What is the role of balneotherapy associated with exercise? A systematic review |
Front Physiol. 2022 Aug 10;13:964232. doi: 10.3389/fphys.2022.964232. eCollection 2022.
Lucia Castelli 1, Letizia Galasso 1, Antonino Mulè 1, Andrea Ciorciari 1, Francesca Fornasini 2, Angela Montaruli 1 3, Eliana Roveda 1 3, Fabio Esposito 1 3 |
| 32 | |
Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP) |
Ann Rheum Dis. 2022 Aug 12;annrheumdis-2022-222641. doi: 10.1136/ard-2022-222641.Online ahead of print.
Yvette Meissner 1, Anja Strangfeld 2 3, Anna Molto 4 5, Frauke Forger 6, Marianne Wallenius 7 8, Nathalie Costedoat-Chalumeau 9 10, Hilde Bjørngaard 8, Marion Couderc 11 12, René-Marc Flipo 13, Gaëlle Guettrot-Imbert 9, Isabell Haase 14, Bente Jakobsen 8, Hege Suorza Svean Koksvik 8, Christophe Richez 15 16, Jérémie Sellam 17 18, Anja Weiß 2, Astrid Zbinden 6, Rebecca Fischer-Betz 19 |
| 33 | |
Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study |
ACR Open Rheumatol. 2022 Sep;4(9):794-801. doi: 10.1002/acr2.11469. Epub 2022 Jun 22.
Philip C Robinson 1, Walter P Maksymowych 2, Lianne S Gensler 3, Stephen Hall 4, Martin Rudwaleit 5, Bengt Hoepken 6, Lars Bauer 6, Thomas Kumke 6, Mindy Kim 7, Natasha de Peyrecave 8, Atul Deodhar 9 |
| 34 | |
Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies |
Semin Arthritis Rheum. 2022 Jul 21;56:152074.doi: 10.1016/j.semarthrit.2022.152074. Online ahead of print.
Christian Lynæs 1, Maria Lynæs 2, Lee S Simon 3, Peter Tugwell 4, Maria-Antonietta D'Agostino 5, Vibeke Strand 6, Carsten B Juhl 7, Sabrina M Nielsen 8, Maarten De Witt 9, Dorcas Beaton 10, Lara J Maxwell 11, Alexa S Meara 12, Robin Christensen 13, on-behalf-of-the-OMERACT-Technical-Advisory-Group-(TAG) |
| 35 | |
Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis |
Clin Exp Rheumatol. 2022 Jul;40(7):1442-1446. doi: 10.55563/clinexprheumatol/gyrtjo.Epub 2022 Apr 20.
Hemalatha Srinivasalu 1, Melissa Oliver 2, Matthew L Stoll 3, Pamela F Weiss 4, Robert A Colbert 5, CARRA Juvenile Spondyloarthritis Workgroup |
| 36 | |
Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST |
RMD Open. 2022 Jul;8(2):e002165. doi: 10.1136/rmdopen-2021-002165.
Jürgen Braun 1, Uta Kiltz 2, Atul Deodhar 3, Tetsuya Tomita 4, Maxime Dougados 5, Rebecca Bolce 6, David Sandoval 6, Chen-Yen Lin 6, Jessica Walsh 7 |
| 37 | |
Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study |
ACR Open Rheumatol. 2022 Jul 14;10.1002/acr2.11486. doi: 10.1002/acr2.11486.Online ahead of print.
Philip C Robinson 1, Pedro M Machado 2, Nigil Haroon 3, Lianne S Gensler 4, John D Reveille 5, Vanessa Taieb 6, Thomas Vaux 7, Carmen Fleurinck 8, Marga Oortgiesen 9, Natasha de Peyrecave 8, Atul Deodhar 10 |
| 38 | |
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension |
RMD Open. 2022 Jul;8(2):e002280.doi: 10.1136/rmdopen-2022-002280.
Désirée van der Heijde 1, Atul Deodhar 2, Walter P Maksymowych 3, Joachim Sieper 4, Filip Van den Bosch 5, Tae-Hwan Kim 6, Mitsumasa Kishimoto 7, Andrew J Östör 8, Bernard Combe 9, Yunxia Sui 10, Yuanyuan Duan 10, Peter K Wung 10, In-Ho Song 10 |
| 39 | |
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial |
J Rheumatol. 2022 Jul 15;jrheum.211075. doi: 10.3899/jrheum.211075. Online ahead of print.
Emilce E Schneeberger 1, Gustavo Citera 1, Dario Ponce de Leon 1, Annette E Szumski 1, Kenneth Kwok 1, Mariel Cutri 1, Maxime Dougados 1 |
| 40 | |
The risk of inflammatory bowel disease in patients with axial spondyloarthritis treated with biologic agents: BSRBR-AS and meta-analysis |
J Rheumatol. 2022 Jul 1;jrheum.211034. doi: 10.3899/jrheum.211034. Online ahead of print.
Gary J Macfarlane 1, Renke Biallas 1, Linda E Dean 1, Gareth T Jones 1, Nicola J Goodson 1, Ovidiu Rotariu 1 |
| 41 | |
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity |
Arthritis Res Ther. 2022 Jul 7;24(1):163. doi: 10.1186/s13075-022-02853-3.
P R Sternes 1, L Brett 2, J Phipps 3, F Ciccia 4, T Kenna 5 6, E de Guzman 5 3, K Zimmermann 6, M Morrison 7, G Holtmann 8, E Klingberg 9, D Mauro 4, C McIvor 2, H Forsblad-d'Elia 9, M A Brown 10 11 |
| 42 | |
A brief human history of ankylosing spondylitis: A scoping review of pathogenesis, diagnosis, and treatment |
Surg Neurol Int. 2022 Jul 15;13:297. doi: 10.25259/SNI_294_2022. eCollection 2022.
Sierra N Murphy 1, Brandon A Nguyen 1, Rohin Singh 1, Nolan J Brown 2, Shane Shahrestani 3, Matthew T Neal 3, Naresh P Patel 3, Maziyar A Kalani 3 |
| 43 | |
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial |
RMD Open. 2022 Jun;8(2):e002253. doi: 10.1136/rmdopen-2022-002253.
Victoria Navarro-Compán 1, James Cheng-Chung Wei 2 3, Filip Van den Bosch 4 5, Marina Magrey 6, Lisy Wang 7, Dona Fleishaker 7, Joseph C Cappelleri 7, Cunshan Wang 7, Joseph Wu 7, Oluwaseyi Dina 8, Lara Fallon 9, Vibeke Strand 10 |
| 44 | |
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab |
Rheumatol Ther. 2022 Jun 8;1-14. doi: 10.1007/s40744-022-00460-x. Online ahead of print.
Uta Kiltz 1 2, Petros P Sfikakis 3, Karl Gaffney 4, Andreas Bounas 5, Nicola Gullick 6 7, Eric Lespessailles 8, Jan Brandt-Juergens 9, Rasho Rashkov 10, Barbara Schulz 11, Effie Pournara 11, Piotr Jagiello 11 |
| 45 | |
Perioperative risk stratification of spine trauma patients with ankylosing spinal disorders: a comparison of 3 quantitative indices |
J Neurosurg Spine. 2022 May 27;1-7. doi: 10.3171/2022.4.SPINE211449. Online ahead of print.
Nikita Lakomkin 1, Anthony L Mikula 1, Zachariah W Pinter 1, Elizabeth Wellings 1, Mohammed Ali Alvi 1, Kristen M Scheitler 1, Zach Pennington 1, Nathan J Lee 2, Brett A Freedman 1, Arjun S Sebastian 1, Jeremy L Fogelson 1, Mohamad Bydon 1, Michelle J Clarke 1, Benjamin D Elder 1 |
| 46 | |
Defining and managing flares in axial spondyloarthritis |
Curr Opin Rheumatol. 2022 Jul 1;34(4):195-202.doi: 10.1097/BOR.0000000000000883. Epub 2022 Jun 9.
|
| 47 | |
Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease |
Cureus. 2022 Jun 3;14(6):e25633. doi: 10.7759/cureus.25633.eCollection 2022 Jun.
Pradnya Brijmohan Bhattad 1, Mugdha Kulkarni 2, Parasbhai D Patel 3, Mazen Roumia 1 |
| 48 | |
Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis |
Arthritis Care Res (Hoboken). 2022 Jul;74(7):1058-1064. doi: 10.1002/acr.24529.Epub 2022 Apr 15.
Pamela F Weiss 1, Robert C Fuhlbrigge 2, Emily von Scheven 3, Daniel J Lovell 4, Robert A Colbert 5, Hermine I Brunner 4, PRCSG Advisory Council and the CARRA Executive Committee |
| 49 | |
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA |
Clin Rheumatol. 2022 Jun 7. doi: 10.1007/s10067-022-06230-y. Online ahead of print.
Theresa Hunter 1, Michael Grabner 2, Julie Birt 3, Keith Isenberg 4, Mingyang Shan 3, Chia-Chen Teng 2, Jianmin Wu 3, Kirstin Griffing 3, Jeffrey Lisse 3, Jeffrey R Curtis 5 |
| 50 | |
Concurrence of Rheumatoid Arthritis and Ankylosing Spondylitis: Analysis of Seven Cases and Literature Review |
Case Rep Rheumatol. 2022 May 28;2022:8500567.doi: 10.1155/2022/8500567. eCollection 2022.
Bryan-Josué Flores-Robles 1, Eztizen Labrador-Sánchez 1, Estíbaliz Andrés-Trasahedo 1, Valvanera Pinillos-Aransay 1, María-Yasmina Joven-Zapata 2, Laura Torrecilla Lerena 2, Osman-Alberto Salazar-Asencio 3, Juan-Antonio López-Martín 1 |
| 51 | |
Mortality Rates in Patients With Ankylosing Spondylitis With and Without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study |
J Rheumatol. 2022 Jul;49(7):688-693. doi: 10.3899/jrheum.210909. Epub 2022 Apr 15.
Erin Kelty 1, Milica Ognjenovic 2, Warren D Raymond 2, Charles A Inderjeeth 3, Helen I Keen 4, David B Preen 5, Johannes C Nossent 3 |
| 52 | |
Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database |
BMC Rheumatol. 2022 Jun 30;6(1):44. doi: 10.1186/s41927-022-00275-x.
Mohamad Bittar 1, Sali Merjanah 2 3, Reem Alkilany 3, Marina Magrey 4 |
| 53 | |
Does Gender Impact a Diagnosis of Ankylosing Spondylitis? |
ACR Open Rheumatol. 2022 Jun;4(6):540-546. doi: 10.1002/acr2.11428. Epub 2022 Mar 29.
Mark C Hwang 1, Martin Rozycki 2, David Kauffman 3, Theresa Arndt 2, Esther Yi 4, Michael H Weisman 5 |
| 54 | |
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety |
Pharmacol Ther. 2022 Jan;229:107925. doi: 10.1016/j.pharmthera.2021.107925.Epub 2021 Jun 23.
Frank Kolbinger 1, Franco Di Padova 2, Atul Deodhar 3, Jason E Hawkes 4, Christine Huppertz 2, Torsten Kuiper 2, Iain B McInnes 5, Christopher T Ritchlin 6, David Rosmarin 7, Georg Schett 8, José M Carballido 2, Peter Häusermann 9, Claudio Calonder 2, Beate Vogel 2, Jean-Michel Rondeau 2, Gerard Bruin 2 |
| 55 | |
Fertility and pregnancy outcomes in women with spondyloarthritis: a systematic review and meta-analysis |
Rheumatology (Oxford). 2022 Apr 11;61(4):1314-1327.doi: 10.1093/rheumatology/keab589.
Sabrina Hamroun 1, Aghilès Hamroun 2, Jean-Joël Bigna 3, Edem Allado 4, Frauke Förger 5, Anna Molto 6 |
| 56 | |
Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review |
BMC Musculoskelet Disord. 2022 Mar 12;23(1):240.doi: 10.1186/s12891-022-05073-7.
|
| 57 | |
Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial |
Arthritis Care Res (Hoboken). 2022 Mar;74(3):451-460. doi: 10.1002/acr.24482.Epub 2022 Jan 26.
Jessica A Walsh 1, Marina N Magrey 2, Xenofon Baraliakos 3, Kentaro Inui 4, Meng-Yu Weng 5, Ennio Lubrano 6, Désirée van der Heijde 7, Annelies Boonen 8, Lianne S Gensler 9, Vibeke Strand 10, Jürgen Braun 3, Theresa Hunter 11, Xiaoqi Li 11, Baojin Zhu 11, Luis León 11, David Marcelino Sandoval Calderon 11, Uta Kiltz 3 |
| 58 | |
Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled Trials |
Arthritis Care Res (Hoboken). 2022 May;74(5):759-767. doi: 10.1002/acr.24517.Epub 2022 Mar 10.
Tore K Kvien 1, Philip G Conaghan 2, Laure Gossec 3, Vibeke Strand 4, Mikkel Østergaard 5, Denis Poddubnyy 6, Nicole Williams 7, Brian Porter 8, Abhijit Shete 9, Isabelle Gilloteau 9, Atul Deodhar 10 |
| 59 | |
Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials |
Adv Ther. 2022 Jun;39(6):2806-2819.doi: 10.1007/s12325-022-02132-2. Epub 2022 Apr 16.
Irene E van der Horst-Bruinsma 1, Kurt de Vlam 2, Jessica A Walsh 3, Rebecca Bolce 4, Theresa Hunter 4, David Sandoval 4, Danting Zhu 4, Vladimir Geneus 4, Enrique R Soriano 5, Marina Magrey 6 |
| 60 | |
The effect of exercise training programs with aerobic components on C-reactive protein, erythrocyte sedimentation rate and self-assessed disease activity in people with ankylosing spondylitis: A systematic review and meta-analysis |
Int J Rheum Dis. 2022 Mar 10. doi: 10.1111/1756-185X.14315. Online ahead of print.
|
| 61 | |
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials |
Semin Arthritis Rheum. 2022 Jun;54:151996.doi: 10.1016/j.semarthrit.2022.151996. Epub 2022 Mar 19.
|
| 62 | |
Treatment of axial spondyloarthritis: an update |
Nat Rev Rheumatol. 2022 Apr;18(4):205-216. doi: 10.1038/s41584-022-00761-z.Epub 2022 Mar 10.
|
| 63 | |
Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis |
JAMA Netw Open. 2022 Mar 1;5(3):e222312.doi: 10.1001/jamanetworkopen.2022.2312.
|
| 64 | |
Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1 |
BMC Musculoskelet Disord. 2021 Dec 13;22(1):1037.doi: 10.1186/s12891-021-04930-1. Jürgen Braun 1, Bjoern Buehring 2, Xenofon Baraliakos 2, Lianne S Gensler 3, Brian Porter 4, Erhard Quebe-Fehling 5, Sibylle Haemmerle 5 |
| 65 | |
The effectiveness of group and home-based exercise on psychological status in people with ankylosing spondylitis: A systematic review and meta-analysis |
Musculoskeletal Care. 2022 Apr 18. doi: 10.1002/msc.1641. Online ahead of print.
Brian Lane 1, Ruth McCullagh 1, Jefferson R Cardoso 2, Joseph G McVeigh 1 |
| 66 | |
Waiting for JAK inhibitor safety data |
RMD Open. 2022 Feb;8(1):e002236.doi: 10.1136/rmdopen-2022-002236.
Tue Wenzel Kragstrup 1 2, Bente Glintborg 3 4, Annemarie L Svensson 5, Christopher McMaster 6 7 8, Philip C Robinson 9 10, Bent Deleuran 11 12, David Fl Liew 13 7 14 |
| 67 | |
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial) |
Rheumatology (Oxford). 2022 May 5;61(5):2063-2071.doi: 10.1093/rheumatology/keab543.
Walter P Maksymowych 1, Mikkel Østergaard 2 3, Robert Landewé 4, William Barchuk 5, Ke Liu 5, Chantal Tasset 6, Leen Gilles 7, Thijs Hendrikx 8, Robin Besuyen 9, Xenofon Baraliakos 10 |
| 68 | |
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension |
Arthritis Rheumatol. 2022 Jan;74(1):70-80.doi: 10.1002/art.41911. Epub 2021 Nov 12.
Atul Deodhar 1, Désirée van der Heijde 2, Joachim Sieper 3, Filip Van den Bosch 4, Walter P Maksymowych 5, Tae-Hwan Kim 6, Mitsumasa Kishimoto 7, Andrew Ostor 8, Bernard Combe 9, Yunxia Sui 10, Alvina D Chu 10, In-Ho Song 10 |
| 69 | |
The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment |
J Rheumatol. 2022 Feb;49(2):225-229. doi: 10.3899/jrheum.210742. Epub 2021 Oct 1.
James T Rosenbaum 1, Michael H Weisman 2, Hedley Hamilton 3, Cassie Shafer 4, Elin Aslanyan 4, Richard A Howard 4, Kimberly Ogle 5, John D Reveille 6, Kevin L Winthrop 7, Dongseok Choi 7 |
| 70 | |
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study |
RMD Open. 2022 Mar;8(1):e002138.doi: 10.1136/rmdopen-2021-002138.
Désirée van der Heijde 1, Lianne S Gensler 2, Walter P Maksymowych 3, Robert Landewé 4 5, Martin Rudwaleit 6, Lars Bauer 7, Thomas Kumke 7, Mindy Kim 8, Simone Emanuele Auteri 9, Bengt Hoepken 7, Atul Deodhar 10 |
| 71 | |
Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab |
Arthritis Care Res (Hoboken). 2022 Feb;74(2):259-267. doi: 10.1002/acr.24442.Epub 2021 Dec 29. Laura C Coates 1, Sonya Abraham 2, William Tillett 3, Philip J Mease 4, Sofia Ramiro 5, Tianshuang Wu 6, Xin Wang 6, Aileen L Pangan 6, In-Ho Song 6 |
| 72 | |
All-Cause and Cause-Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta-Analysis |
Arthritis Care Res (Hoboken). 2021 Nov 17. doi: 10.1002/acr.24820. Online ahead of print. Haseeb Chaudhary 1, Nidrit Bohra 1, Khezar Syed 1, Anthony Donato 1, M Hassan Murad 2, Paras Karmacharya 3 4 |
| 73 | |
A Road Map of the Axial Spondyloarthritis Continuum |
Mayo Clin Proc. 2022 Jan;97(1):134-145. doi: 10.1016/j.mayocp.2021.08.007.Epub 2021 Nov 18. Sergio Schwartzman 1, Eric M Ruderman 2 |
| 74 | |
IL-23 and axial disease: do they come together? |
Rheumatology (Oxford). 2021 Oct 19;60(Suppl 4):iv28-iv33.doi: 10.1093/rheumatology/keab617. Philip Mease 1 2, Filip van den Bosch 3 |
| 75 | |
Subcutaneous Infliximab, CT-P13 SC: A Profile of Its Use in the EU |
Clin Drug Investig. 2021 Dec;41(12):1099-1107. doi: 10.1007/s40261-021-01093-8.Epub 2021 Nov 2. Matt Shirley 1 |
| 76 | |
Comparison of Outcomes in Percutaneous Fixation of Traumatic Fractures between Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis |
Global Spine J. 2021 Oct 20;21925682211052003. doi: 10.1177/21925682211052003.Online ahead of print. Scott McCarty 1, Jacob J Bruckner 2, Jael E Camacho 2, Julio J Jauregui 2, Alexandra E Thomson 2, Ivan Ye 2, Daniel L Cavanaugh 2, Eugene Y Koh 2, Steven C Ludwig 2, Daniel E Gelb 2 |
| 77 | |
ACR Appropriateness Criteria® Inflammatory Back Pain: Known or Suspected Axial Spondyloarthritis: 2021 Update |
J Am Coll Radiol. 2021 Nov;18(11S):S340-S360.doi: 10.1016/j.jacr.2021.08.003. Expert Panel on Musculoskeletal Imaging; Gregory J Czuczman 1, Jacob C Mandell 2, Daniel E Wessell 3, Leon Lenchik 4, Shivani Ahlawat 5, Jonathan C Baker 6, R Carter Cassidy 7, Jennifer L Demertzis 8, Hillary W Garner 9, Alan Klitzke 10, Jennifer R Maynard 11, Jennifer L Pierce 12, Charles Reitman 13, Ralf Thiele 14, William J Yost 15, Francesca D Beaman 16 |
| 78 | |
Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study |
Rheumatol Ther. 2021 Dec 19. doi: 10.1007/s40744-021-00406-9. Online ahead of print. Atul Deodhar 1, Denise Kruzikas 2, Lili Zhou 2, Ana Biljan 2, Christopher D Saffore 2 |
| 79 | |
Impact of age on mortality and complications in patients with Ankylosing Spondylitis spine fractures |
J Clin Neurosci. 2022 Jan;95:188-197. doi: 10.1016/j.jocn.2021.11.035. Epub 2021 Dec 17. Mayur Sharma 1, Nikhil Jain 1, Dengzhi Wang 1, Beatrice Ugiliweneza 2, Maxwell Boakye 3, Doniel Drazin 4 |
| 80 | |
Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen-B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry |
ACR Open Rheumatol. 2022 Feb 26.doi: 10.1002/acr2.11416. Online ahead of print. Philip J Mease 1, Soumya D Chakravarty 2, Robert R McLean 3, Taylor Blachley 3, Toana Kawashima 3, Iris Lin 4, Arthur Kavanaugh 5, Alexis Ogdie 6 |
| 81 | |
Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study |
CMAJ Open. 2022 Feb 15;10(1):E109-E118. doi: 10.9778/cmajo.20200319. Print Jan-Mar 2022. Anat Fisher 1, Jason D Kim 2, Colin R Dormuth 2 |
| 82 | |
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study |
J Clin Med. 2022 Jan 26;11(3):621. doi: 10.3390/jcm11030621. Simone Parisi 1, Andrea Becciolini 2, Maria Chiara Ditto 1, Davide Rozza 3, Anna Zanetti 3, Angela Laganà 1, Clara Lisa Peroni 1, Chiara Centanaro Di Vittorio 1, Rosanna Degiovanni 1, Cristina Realmuto 1, Carlo Alberto Scirè 3, Marta Priora 4, Eleonora Di Donato 2, Daniele Santilli 2, Flavio Mozzani 2, Gianluca Lucchini 2, Alarico Ariani 2, Lucia Gardelli 5, Francesco Girelli 5, Eugenio Arrigoni 6, Ilaria Platè 6, Elena Bravi 6, Marino Paroli 7, Rosalba Caccavale 7, Carlo Salvarani 8, Gilda Sandri 8, Federica Lumetti 9, Alessandro Volpe 10, Antonio Marchetta 10, Enrico Fusaro 1 |
| 83 | |
Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1) |
Rheumatol Adv Pract. 2021 Dec 4;5(3):rkab098. doi: 10.1093/rap/rkab098. eCollection 2021. Stephanie Rose Harrison 1 2, Marco Garrido-Cumbrera 3 4, Victoria Navarro-Compán 5, José Correa-Fernández 3, Dale Webb 6, Laura Christen 7, Helena Marzo-Ortega 1 2 |
| 84 | |
Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset |
ACR Open Rheumatol. 2022 Jan 5. doi: 10.1002/acr2.11388. Online ahead of print. Sarah B Lieber 1 2, Iris Navarro-Millán 1 2, Mangala Rajan 2, Jeffrey R Curtis 3, Sebastian E Sattui 4, Geyanne Lui 5, Sergio Schwartzman 1 2, Lisa A Mandl 1 2 |
| 85 | |
Diagnostic delay in axial spondyloarthritis: a systematic review |
Clin Rheumatol. 2022 Feb 19. doi: 10.1007/s10067-022-06100-7.Online ahead of print. Charles A Hay 1, Jon Packham 1 2 3, Sarah Ryan 3 4, Christian D Mallen 1 3, Alexandros Chatzixenitidis 1, James A Prior 5 6 |
| 86 | |
Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs |
RMD Open. 2022 Jan;8(1):e001777. doi: 10.1136/rmdopen-2021-001777. Monica Schwartzman 1, Joerg Ermann 2, Kristine A Kuhn 3, Sergio Schwartzman 4, Michael H Weisman 5 |
| 87 | |
Patient Perspectives on Biologics for Axial Spondyloarthritis in a Cross-sectional Study in a Predominantly Female Population: Treatment Satisfaction, Wear-off Between Doses, and Use of Supplemental Medication |
Rheumatol Ther. 2021 Dec 27. doi: 10.1007/s40744-021-00417-6. Online ahead of print. W Benjamin Nowell 1, Kelly Gavigan 2, Theresa Hunter 3, Rebecca J Bolce 3, Jeffrey R Lisse 3, Carol Himelein 3, Suchita Dubey 3, Jeffrey R Curtis 4, Jessica A Walsh 5 |
| 88 | |
Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades |
MD Open. 2021 Dec;7(3):e001888. doi: 10.1136/rmdopen-2021-001888. Samantha S R Crossfield 1 2, Helena Marzo-Ortega 2 3, Sarah R Kingsbury 2 3, Mar Pujades-Rodriguez 4, Philip G Conaghan 2 3 |
| 89 | |
Evaluation of Clinical Diagnosis of Axial Psoriatic Arthritis (PsA) or Elevated Patient-reported Spine Pain in CorEvitas' PsA/Spondyloarthritis Registry |
J Rheumatol. 2021 Dec 1;jrheum.210662. doi: 10.3899/jrheum.210662. Online ahead of print. Alexis Ogdie 1, Taylor Blachley 1, Paul R Lakin 1, Blessing Dube 1, Robert R McLean 1, Peter Hur 1, Philip J Mease 1 |
| 90 | |
Determinants of the Physician Global Assessment of Disease Activity and Influence of Contextual Factors in Early Axial Spondyloarthritis |
Arthritis Care Res (Hoboken). 2022 Feb;74(2):268-273. doi: 10.1002/acr.24465.Epub 2022 Jan 13. Fumio Hirano 1, Robert B M Landewé 2, Floris A van Gaalen 1, Désirée van der Heijde 1, Cécile Gaujoux-Viala 3, Sofia Ramiro 4 |
| 91 | |
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data |
Eur J Health Econ. 2022 Feb 3. doi: 10.1007/s10198-022-01429-x. Online ahead of print Aileen R Neilson 1, Gareth T Jones 2, Gary J Macfarlane 2, Ejaz Mi Pathan 3, Paul McNamee 4 |
| 92 | |
Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI) |
Rheumatol Int. 2022 Jan 28. doi: 10.1007/s00296-021-05067-z. Online ahead of print. Sinead Maguire 1 2, Gillian Fitzgerald 3 4, Phil Gallagher 5, Finbar O'Shea 6 7 |
| 93 | |
Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the RUNX3Promoter |
Front Genet. 2022 Jan 7;12:741867. doi: 10.3389/fgene.2021.741867. eCollection 2021. Carla J Cohen 1 2, Connor Davidson 1 2 3, Carlo Selmi 4, Paul Bowness 1 2, Julian C Knight 3, B Paul Wordsworth 1 2, Matteo Vecellio 1 2 4 |
| 94 | |
Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy |
Scand J Rheumatol. 2022 Jan 20;1-8. doi: 10.1080/03009742.2021.2007609.Online ahead of print. S Maguire 1 2, F Wilson 3, P Gallagher 4, F D O'Shea 1 2 |
| 95 | |
Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort |
J Rheumatol. 2021 Nov;48(11):1672-1679. doi: 10.3899/jrheum.200872. Epub 2020 Dec 15. Elisabeth Mogard 1, Tor Olofsson 2, Stefan Bergman 3, Ann Bremander 4, Lars Erik Kristensen 5, Jack Kvistgaard Olsen 6, Johan K Wallman 2, Elisabet Lindqvist 2 |
| 96 | |
Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry |
Rheumatology (Oxford). 2021 Dec 1;60(12):5795-5800.doi: 10.1093/rheumatology/keab070. Xabier Michelena 1 2, Sizheng Steven Zhao 3, Sayam Dubash 1 2, Linda E Dean 4, Gareth T Jones 4, Helena Marzo-Ortega 1 2 |
| 97 | |
Concurrent chronic hyperplastic candidosis and oral lichenoid lesion as adverse events of secukinumab therapy |
Aust Dent J. 2021 Sep;66(3):340-345. doi: 10.1111/adj.12833.Epub 2021 Mar 5. |
| 98 | |
Clinical Manifestations and Diagnosis of Axial Spondyloarthritis |
J Clin Rheumatol. 2021 Dec 1;27(8):e547-e560.doi: 10.1097/RHU.0000000000001575. |
| 99 | |
Understanding Fatigue-Related Disability in Rheumatoid Arthritis and Ankylosing Spondylitis: The Importance of Daily Correlates |
Arthritis Care Res (Hoboken). 2021 Sep;73(9):1282-1289. doi: 10.1002/acr.24224.Epub 2021 Aug 6. Roisin S M Hegarty 1, Tamlin S Conner 1, Simon Stebbings 2, Benjamin D Fletcher 1, Andrew Harrison 3, Gareth J Treharne 1 |
| 100 | |
What Have We Learned From Family-Based Studies About Spondyloarthritis? |
Front Genet. 2021 Jun 3;12:671306. doi: 10.3389/fgene.2021.671306.eCollection 2021. Félicie Costantino 1 2, Hendrick Mambu Mambueni 1, Roula Said-Nahal 1 2, Henri-Jean Garchon 1 3, Maxime Breban 1 2 |
| 101 | |
Imaging in Axial Spondyloarthritis: What is Relevant for Diagnosis in Daily Practice? |
Curr Rheumatol Rep. 2021 Jul 3;23(8):66. doi: 10.1007/s11926-021-01030-w. Ulrich Weber 1, Anne Grethe Jurik 2 3 4, Robert G W Lambert 5 6, Walter P Maksymowych 7 |
| 102 | |
Effects of a 6-month exercise programme on disease activity, physical and functional parameters in patients with ankylosing spondylitis: Randomised controlled trial |
S Afr J Physiother. 2021 Jun 29;77(1):1546. doi: 10.4102/sajp.v77i1.1546.eCollection 2021. Kim Nolte 1, Dina C Janse van Rensburg 2, Lizelle Fletcher 3 |
| 103 | |
Subjective loss of clinical response to TNFi in axSpA relates to recurrence of MRI bone marrow oedema particularly with long-acting agents |
Rheumatology (Oxford). 2021 Jul 17;keab571. doi: 10.1093/rheumatology/keab571.Online ahead of print. Stephanie R Harrison 1 2, Rebecca Ansell 1 3, Hannah R Mathieson 1 2 3, Mira Merashli 4, Noemi Busquets-Péez 5, Dennis McGonagle 1 2, Helena Marzo-Ortega 1 2 |
| 104 | |
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy |
Med Clin North Am. 2021 Mar;105(2):325-339. doi: 10.1016/j.mcna.2020.10.001.Epub 2021 Jan 14. |
| 105 | |
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis |
Rheumatol. 2021 Feb 15;jrheum.201088. doi: 10.3899/jrheum.201088. Online ahead of print. Peter C Taylor 1, Désirée van der Heijde 1, Robert Landewé 1, Shannon McCue 1, Sue Cheng 1, Annelies Boonen 1 |
| 106 | |
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review |
BioDrugs. 2021 Mar;35(2):175-186. doi: 10.1007/s40259-021-00467-w. Epub 2021 Feb 17. Elisabetta Chessa 1, Matteo Piga 2, Alberto Floris 1, Mattia Congia 1, Ignazio Cangemi 1, Alessandro Mathieu 1, Alberto Cauli 1 |
| 107 | |
Revision and 90-day mortality following hip arthroplasty in patients with inflammatory arthritis and ankylosing spondylitis enrolled in the National Joint Registry for England and Wales |
Hip Int. 2021 Feb 18;1120700021990592. doi: 10.1177/1120700021990592. Online ahead of print. Laura L Miller 1, Daniel Prieto-Alhambra 2, Lea Trela-Larsen 1, J Mark Wilkinson 3, Emma M Clark 1, Ashley W Blom 1, Alexander J MacGregor 4 |
| 108 | |
Primary Total Hip Arthroplasty in Patients With Ankylosing Spondylitis |
J Arthroplasty. 2021 Jul;36(7S):S282-S289. doi: 10.1016/j.arth.2021.01.054. Epub 2021 Jan 23. Brandon R Bukowski 1, Nicholas J Clark 1, Michael J Taunton 1, Brett A Freedman 1, Daniel J Berry 1, Matthew P Abdel 1 |
| 109 | |
Axial spondyloarthritis: new advances in diagnosis and management |
BMJ. 2021 Jan 4;372:m4447. doi: 10.1136/bmj.m4447. |
| 110 | |
A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting |
S Afr Med J. 2020 Nov 27;110(12):1231-1237. doi: 10.7196/SAMJ.2020.v110i12.14695. |
| 111 | |
Increased proportion of comorbidities but no deterioration of sexual QOL during a 5-year follow-up in patients with axSpA in the biologic treatment era |
Rheumatology (Oxford). 2021 Jan 7;keaa887. doi: 10.1093/rheumatology/keaa887.Online ahead of print. Kari Hansen Berg 1, Gudrun Rohde 1 2, Are Pripp 3, Anne Prøven 4, Esben Ester Pirelli Benestad 1, Monika Østensen 2, Glenn Haugeberg 2 5 |
| 113 | |
Treat-to-target in axial spondyloarthritis: an observational study in daily practice |
Rheumatology (Oxford). 2021 Jun 27;keab516. doi: 10.1093/rheumatology/keab516.Online ahead of print. Esther Beckers 1 2, Annelies Boonen 1 2, Casper Webers 1 2, Peter Ten Klooster 3, Harald Vonkeman 3 4, Monique Efdé 5, Astrid van Tubergen 1 2 |
| 114 | |
Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time |
RMD Open. 2020 Nov;6(3):e001418. doi: 10.1136/rmdopen-2020-001418. Karim Doughem 1, Michael H Weisman 2, Michael M Ward 3, Lianne S Gensler 4, Mariko Ishimori 5, Amirali Tahanan 6, David C Kung 7, Laura Diekman 8, MinJae Lee 9, Mohammad Hossein Rahbar 6, John D Reveille 8 |
| 115 | |
Identifying Patients With Axial Spondyloarthritis in Large Datasets: Expanding Possibilities for Observational Research |
J Rheumatol. 2021 May;48(5):685-692. doi: 10.3899/jrheum.200570. Epub 2020 Sep 1. Jessica A Walsh 1, Shaobo Pei 2, Gopi K Penmetsa 2, Rebecca S Overbury 2, Daniel O Clegg 2, Brian C Sauer 2 |
| 116 | |
Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives |
Open Access Rheumatol. 2020 Nov 26;12:277-292. doi: 10.2147/OARRR.S265806.eCollection 2020. |
| 117 | |
Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management |
Ther Adv Musculoskelet Dis. 2020 Nov 2;12:1759720X20970028. doi: 10.1177/1759720X20970028. eCollection 2020. Joel T Parkinson 1, Éimear M Foley 2, Deepak R Jadon 3, Golam M Khandaker 2 |
| 118 | |
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? |
Nat Rev Rheumatol. 2021 Jun 10. doi: 10.1038/s41584-021-00625-y.Online ahead of print. Daniele Mauro 1, Ranjeny Thomas 2, Giuliana Guggino 3, Rik Lories 4 5, Matthew A Brown 6, Francesco Ciccia 7 |
| 119 | |
Children with enthesitis-related arthritis could benefit from treatments targeted for adults with spondyloarthritis |
Arthritis Care Res (Hoboken). 2020 Dec 5. doi: 10.1002/acr.24529.Online ahead of print. Pamela F Weiss 1, Robert C Fuhlbrigge 2, Emily von Scheven 3, Daniel J Lovell 4, Robert A Colbert 5, Hermine I Brunner 4, PRCSG Advisory Council, the CARRA Executive Committee |
| 120 | |
Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six-Month Results of a Placebo-Controlled Trial |
Arthritis Rheumatol. 2021 May;73(5):806-815.doi: 10.1002/art.41607. Epub 2021 Mar 24. Tamara Rusman 1, Mignon A C van der Weijden 1, Michael T Nurmohamed 2, Robert B M Landewé 3, Janneke J H de Winter 3, Bouke J H Boden 4, Pierre M Bet 1, Carmella M A van der Bijl 1, Conny van der Laken 1, Irene E van der Horst-Bruinsma 1 |
| 121 | |
One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis |
Arthritis Care Res (Hoboken). 2020 Nov 30. doi: 10.1002/acr.24523. Online ahead of print. Bente Glintborg 1 2, Ulf Lindstrom 3, Daniela Di Giuseppe 4, Sella Aarrestad Provan 5, Bjorn Gudbjornsson 6, Merete Lund Hetland 1 2, Brigitte Michelsen 7 8, Johan Wallman 9, Kalle Aaltonen 10, Anna-Mari Hokkanen 11, Dan Nordström 12, Tanja Schjødt Jørgensen 13, Rebekka Lund Hansen 13, Arni Jon Geirsson 14, Kathrine Grøn 1, Niels Steen Krogh 15, Johan Askling 4, Lars Erik Kristensen 13, Lennart Jacobsson 3, DANBIO (Denmark), ARTIS/SRQ (Sweden), ICEBIO (Iceland), ROB-FIN (Finland), NOR-DMARD (Norway) registries |
| 122 | |
Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature |
Front Med (Lausanne). 2021 Apr 26;8:661101. doi: 10.3389/fmed.2021.661101.eCollection 2021. Per Eriksson 1, Johan Mölne 2, Lina Wirestam 1, Christopher Sjöwall 1 |
| 123 | |
A pilot study of a nurse-led integrated care review (the INCLUDE review) for people with inflammatory rheumatological conditions in primary care: feasibility study findings |
Pilot Feasibility Stud. 2021 Jan 6;7(1):9. doi: 10.1186/s40814-020-00750-7. Samantha L Hider 1 2, Milica Bucknall 3 4, Clare Jinks 3 5, Kelly Cooke 6, Kendra Cooke 4, Erandie Ediriweera Desilva 3 7, Andrew G Finney 3 8, Emma L Healey 3, Daniel Herron 3, Annabelle R Machin 3, Christian D Mallen 3 5 9, Simon Wathall 3, Carolyn A Chew-Graham 3 5 9 |
| 124 | |
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement |
Ann Rheum Dis. 2021 Jan;80(1):71-87.doi: 10.1136/annrheumdis-2020-218398. Epub 2020 Nov 6. Peter Nash 1, Andreas Kerschbaumer 2, Thomas Dörner 3, Maxime Dougados 4, Roy M Fleischmann 5, Klaus Geissler 6, Iain McInnes 7, Janet E Pope 8, Désirée van der Heijde 9, Michaela Stoffer-Marx 10, Tsutomu Takeuchi 11, Michael Trauner 12, Kevin L Winthrop 13, Maarten de Wit 14, Daniel Aletaha 2, Xenofon Baraliakos 15, Wolf-Henning Boehncke 16, Paul Emery 17, John D Isaacs 18, Joel Kremer 19, Eun Bong Lee 20, Walter P Maksymowych 21, Marieke Voshaar 14, Lai-Shan Tam 22, Yoshiya Tanaka 23, Filip van den Bosch 24, René Westhovens 25, Ricardo Xavier 26, Josef S Smolen 27 |
| 125 | |
Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features? |
Ther Adv Musculoskelet Dis. 2020 Oct 30;12:1759720X20969260.doi: 10.1177/1759720X20969260. eCollection 2020. |
| 126 | |
The societal impact of a biologic treatment of ankylosing spondylitis: a case study based on secukinumab |
J Comp Eff Res. 2021 Feb;10(2):143-155. doi: 10.2217/cer-2020-0077. Epub 2020 Nov 30. Sebastian Himmler 1, Jennifer C Branner 1, Dennis A Ostwald 1 2 |
| 127 | |
Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic |
J Rheumatol. 2020 Nov 15;jrheum.201017. doi: 10.3899/jrheum.201017. Online ahead of print. Michael D George 1, Shilpa Venkatachalam 1, Shubhasree Banerjee 1, Joshua F Baker 1, Peter A Merkel 1, Kelly Gavigan 1, David Curtis 1, Maria I Danila 1, Jeffrey R Curtis 1, W Benjamin Nowell 1 |
| 128 | |
Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis |
Semin Arthritis Rheum. 2020 Dec;50(6):1269-1279.doi: 10.1016/j.semarthrit.2020.08.011. Epub 2020 Aug 29. Sinead Maguire 1, Tom O'Dwyer 2, David Mockler 3, Finbar O'Shea 4, Fiona Wilson 5 |
| 129 | |
Comparison of Men and Women With Axial Spondyloarthritis in the US-Based Corrona Psoriatic Arthritis/Spondyloarthritis Registry |
J Rheumatol. 2021 Apr 15;jrheum.201549. doi: 10.3899/jrheum.201549. Online ahead of print. Philip J Mease 1, Robert R McLean 1, Blessing Dube 1, Mei Liu 1, Sabrina Rebello 1, Meghan Glynn 1, Esther Yi 1, Yujin Park 1, Alexis Ogdie 1 |
| 130 | |
Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients |
Rheumatol Ther. 2021 Apr 17. doi: 10.1007/s40744-021-00306-y. Online ahead of print. James Pike 1, Yan Dong 2, James Piercy 1, Nicola Booth 3, Elizabeth Holdsworth 1, Theresa Hunter 2 |
| 131 | |
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT) |
Arthritis Res Ther. 2020 Sep 29;22(1):225. doi: 10.1186/s13075-020-02305-w. Casper Webers 1 2, Carmen Stolwijk 3, Olga Schiepers 4, Thea Schoonbrood 5, Astrid van Tubergen 5 6, Robert Landewé 7 8, Désirée van der Heijde 9, Annelies Boonen 5 6 |
| 132 | |
Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis |
Front Immunol. 2021 Mar 19;12:614255.doi: 10.3389/fimmu.2021.614255.eCollection 2021. Dennis McGonagle 1 2, Abdulla Watad 1 3 4, Kassem Sharif 1 3 4, Charlie Bridgewood 1 |
| 133 | |
Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) |
RMD Open. 2021 Apr;7(1):e001546. doi: 10.1136/rmdopen-2020-001546. Marco Garrido-Cumbrera 1 2, Helena Marzo-Ortega 3 4, Laura Christen 5, Pedro Plazuelo-Ramos 2, Dale Webb 6, Clare Jacklin 7, Shantel Irwin 8, Laurent Grange 9 10, Souzi Makri 11, Elsa Frazão Mateus 12, Serena Mingolla 13, Katy Antonopoulou 14, Sergio Sanz-Gómez 1, José Correa-Fernández 1, Loreto Carmona 15, Victoria Navarro-Compán 16 |
| 134 | |
Gait characteristics in patients with ankylosing spondylitis: a systematic review |
Clin Exp Rheumatol. Jan-Feb 2021;39(1):173-186. Epub 2020 Oct 5. Julie Soulard 1, Jacques Vaillant 2, Clara-Themis Agier 2, Nicolas Vuillerme 3 |
| 135 | |
Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F |
Front Immunol. 2020 Aug 21;11:1894. doi: 10.3389/fimmu.2020.01894. eCollection 2020. Ralph Adams 1, Asher Maroof 2, Terry Baker 1, Alastair D G Lawson 3, Ruth Oliver 4, Ross Paveley 5, Steve Rapecki 1, Stevan Shaw 2, Pavan Vajjah 4, Shauna West 5, Meryn Griffiths 6 |
| 137 | |
Ankylosing spondylitis and undifferentiated spondyloarthritis: The relationship between living with these diseases and psychological well-being |
Musculoskeletal Care. 2020 Sep 18. doi: 10.1002/msc.1513. Online ahead of print. |
| 138 | |
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment |
Rheumatol Ther. 2020 Dec;7(4):867-882. doi: 10.1007/s40744-020-00233-4.Epub 2020 Sep 16. Luca Navarini 1, Francesco Caso 2, Luisa Costa 3, Damiano Currado 4, Liliana Stola 4, Fabio Perrotta 5, Lorenzo Delfino 6, Michela Sperti 7, Marco A Deriu 7, Piero Ruscitti 8, Viktoriya Pavlych 8, Addolorata Corrado 9, Giacomo Di Benedetto 10 11, Marco Tasso 3, Massimo Ciccozzi 12, Alice Laudisio 13, Claudio Lunardi 6, Francesco Paolo Cantatore 9, Ennio Lubrano 5, Roberto Giacomelli 3 8, Raffaele Scarpa, Antonella Afeltra 4 |
| 139 | |
Performance and Predictors of Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated With Adalimumab |
Arthritis Care Res (Hoboken). 2020 Sep 16. doi: 10.1002/acr.24442. Online ahead of print. Laura C Coates 1, Sonya Abraham 2, William Tillett 3, Philip J Mease 4, Sofia Ramiro 5, Tianshuang Wu 6, Xin Wang 6, Aileen L Pangan 6, In-Ho Song 6 |
| 140 | |
Do All Rigid and Unbalanced Spines Present the Same Risk of Dislocation After Total Hip Arthroplasty? A Comparison Study Between Patients With Ankylosing Spondylitis and History of Spinal Fusion |
J Arthroplasty. 2020 Dec;35(12):3594-3600. doi: 10.1016/j.arth.2020.06.048. Epub 2020 Jun 24. |
| 141 | |
Contemporary Primary Total Knee Arthroplasty is Durable in Patients Diagnosed With Ankylosing Spondylitis |
J Arthroplasty. 2020 Nov;35(11):3161-3165. doi: 10.1016/j.arth.2020.06.033. Epub 2020 Jun 17. Aaron R Owen 1, James R Markos 1, Tad M Mabry 1, Michael J Taunton 1, Daniel J Berry 1, Matthew P Abdel 1 |
| 142 | |
Autoimmune Conditions: Ankylosing Spondylitis |
FP Essent. 2020 Jul;494:30-35. |
| 143 | |
Hearing Loss in Patients With Ankylosing Spondylitis: A Systematic Review and Metaanalysis |
J Rheumatol. 2021 Jan 1;48(1):40-47. doi: 10.3899/jrheum.200276. Epub 2020 May 15. Flora Yan 1, Priyanka D Reddy 2, Shaun A Nguyen 2, Celine Ward 3, Ted A Meyer 2 |
| 144 | |
Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis |
Rheumatology (Oxford). 2020 Dec 1;59(12):3817-3825.doi: 10.1093/rheumatology/keaa166. Michael M Ward 1, Sara Alehashemi 1 |
| 145 | |
Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis |
RMD Open. 2020 May;6(1):e001225. doi: 10.1136/rmdopen-2020-001225. Jean W Liew 1, Irvin J Huang 2, Diana N Louden 3, Namrata Singh 2, Lianne S Gensler 4 |
| 146 | |
Back pain, ankylosing spondylitis and social media usage; a descriptive analysis of current activity |
Rheumatol Int. 2020 Sep;40(9):1493-1499. doi: 10.1007/s00296-020-04600-w.Epub 2020 May 19. Elizabeth Reilly 1 2, Raj Sengupta 3 |
| 147 | |
Revision Total Hip Arthroplasty in Patients With Ankylosing Spondylitis: Long-Term Results |
J Arthroplasty. 2020 Sep;35(9):2573-2580. doi: 10.1016/j.arth.2020.04.071. Epub 2020 Apr 27. Brandon R Bukowski 1, Nicholas J Clark 1, Michael J Taunton 1, Brett A Freedman 1, Daniel J Berry 1, Matthew P Abdel 1 |
| 148 | |
Low Vitamin D Levels Predict Mortality in Ankylosing Spondylitis Patients: A Nationwide Population-Based Cohort Study |
Nutrients. 2020 May 13;12(5):1400. doi: 10.3390/nu12051400. Niv Ben-Shabat 1, Abdulla Watad 1 2 3, Aviv Shabat 4, Nicola Luigi Bragazzi 5, Doron Comaneshter 6, Arnon D Cohen 6 7, Howard Amital 1 2 |